Skip to content

EXOZ EXOZ Common Stock

Common Stock at other companies

Gevo logo
GevoGEVO
$2.43M+1.5%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
15.8B0.0%
NAG
Niagen Bioscience, Inc. Common StockNAGE
150M0.0%
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
50M0.0%
Opko Health logo
Opko HealthOPK
$7.85M+11.9%
Upexi logo
UpexiUPXI
1B+900%

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-5.6%
Enterprise value$76.57M+1.0%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's common stock?
EXOZ (EXOZ) reported common stock of 100M in Q1 2026.
How has EXOZ's common stock changed year-over-year?
EXOZ's common stock decreased by 0.0% year-over-year, from 100M to 100M.
What is the long-term trend for EXOZ's common stock?
Over 2 years (2023 to 2025), EXOZ's common stock has grown at a 0.0% compound annual growth rate (CAGR), from 100M to 100M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).